Concentrating on chromatin-mediated epigenetic regulation has emerged as a possible avenue for developing novel therapeutics for an array of central nervous technique Diseases, like cognitive disorders and melancholy. Histone deacetylase (HDAC) inhibitors are actually pursued as cognitive enhancers that impact the regulation of gene expression and